Spectral AI is trading at $1.65, up 5.10%, rebounding after its August 12, 2026 earnings-related decline.

  • Second-quarter revenue missed estimates despite a narrower loss.
  • The company reaffirmed approximately $18.5 million in 2026 revenue guidance and highlighted FDA-cleared DeepView commercialization.
  • Broader risk appetite is supportive, with major indexes higher after July CPI met expectations and reduced rate-hike fears; no separate August 13 company announcement was identified.